StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

IDEXX Laboratories price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

IDEXX Laboratories's price to sales ratio was 12.2× on Nov 11, 2026, against 14.5× a year earlier. Over the last 5 years it ranged from 8.2× to 17.8×, with a median of 11.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.2×−0.8
2025Dec 31, 202513.0×+4.2
2024Dec 31, 20248.8×−4.0
2023Dec 29, 202312.9×+2.7
2022Dec 30, 202210.1×−7.7
2021Dec 31, 202117.8×+1.4
2020Dec 31, 202016.5×+6.9
2019Dec 31, 20199.5×+2.1
2018Dec 31, 20187.4×+0.0
2017Dec 29, 20177.4×+1.2
2016Dec 30, 20166.2×+1.9
2015Dec 31, 20154.3×−0.9
2014Dec 31, 20145.2×+0.8
2013Dec 31, 20134.3×+0.2
2012Dec 31, 20124.1×+0.3
2011Dec 30, 20113.8×−0.0
2010Dec 31, 20103.8×+0.6
2009Dec 31, 20093.2×–

More IDEXX Laboratories figures

See a number that looks wrong?